Price$6.62-0.12 (-1.78%)
01:30 PM07:45 PM
News · 26 weeks74+340%
2026-01-182026-07-12
Mix4490d
- Insider17(39%)
- SEC Filings12(27%)
- Other10(23%)
- Leadership3(7%)
- Earnings2(5%)
Latest news
25 items- SECSEC Form 144 filed by Butterfly Network Inc.144 - Butterfly Network, Inc. (0001804176) (Subject)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by Butterfly Network Inc.SCHEDULE 13D/A - Butterfly Network, Inc. (0001804176) (Subject)
- INSIDERDirector Rothberg Jonathan M sold $20,765,302 worth of shares (2,799,818 units at $7.42) as part of a pre-agreed trading plan and sold $8,603,330 worth of Class B Common Stock (1,213,634 units at $7.09) as part of a pre-agreed trading plan, decreasing direct ownership by 96% to 105,881 units (SEC Form 4)4 - Butterfly Network, Inc. (0001804176) (Issuer)
- SECSEC Form 144 filed by Butterfly Network Inc.144 - Butterfly Network, Inc. (0001804176) (Subject)
- PRButterfly Network to Report Second Quarter 2026 Financial Results on July 30, 2026Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, announced that it will report second quarter 2026 financial results on Thursday, July 30, 2026, at 8:00 am ET. Joseph DeVivo, President, Chief Executive Officer and Chairman of the Board, and John Doherty, Executive Vice President and Chief Financial Officer, will host a conference call and webcast before the market opens on July 30 to discuss the financial performance and operational progress. The conference call will be broadcast live in listen-only mode via a webcast on Butterfly’s Investor Relations website at Events & Presentations.
- SECSEC Form 144 filed by Butterfly Network Inc.144 - Butterfly Network, Inc. (0001804176) (Subject)
- SECSEC Form 144 filed by Butterfly Network Inc.144 - Butterfly Network, Inc. (0001804176) (Subject)
- INSIDERChief Technology Officer Ku Victor sold $280,665 worth of shares (35,649 units at $7.87), decreasing direct ownership by 3% to 1,063,639 units (SEC Form 4) to cover taxes4 - Butterfly Network, Inc. (0001804176) (Issuer)
- INSIDEREVP, CFO Doherty John N. sold $434,818 worth of shares (55,229 units at $7.87), decreasing direct ownership by 4% to 1,454,412 units (SEC Form 4) to satisfy withholding tax4 - Butterfly Network, Inc. (0001804176) (Issuer)
- INSIDERPresident & CEO Devivo Joseph sold $1,611,800 worth of shares (204,725 units at $7.87), decreasing direct ownership by 3% to 7,883,844 units (SEC Form 4) (tax withholding)4 - Butterfly Network, Inc. (0001804176) (Issuer)
- INSIDERCAO and SVP, Finance Carlson Megan sold $328,937 worth of shares (41,303 units at $7.96), decreasing direct ownership by 8% to 465,906 units (SEC Form 4) to satisfy withholding tax4 - Butterfly Network, Inc. (0001804176) (Issuer)
- SECSEC Form 144 filed by Butterfly Network Inc.144 - Butterfly Network, Inc. (0001804176) (Subject)
- SECSEC Form 144 filed by Butterfly Network Inc.144 - Butterfly Network, Inc. (0001804176) (Subject)
- PRButterfly Network Expands its Handheld Ultrasound Availability into BrazilExpansion into one of Latin America's largest healthcare markets advances Butterfly's international growth strategy and mission to democratize medical imaging Butterfly Network, Inc. ("Butterfly") (NYSE:BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the commercial availability of its Butterfly iQ+ and iQ3 handheld ultrasound devices and mobile application in Brazil through a network of authorized distribution partners. Brazil is the largest medical device market in Latin America and one of the fastest-growing ultrasound markets globally,1,2 representing a significant opportunity to expand access to medical imagi
- PRButterfly Network’s Embedded™ Partner Aleph Neuro Unveils Stunning Brain ImagesBrain-computer interface research lab building on Butterfly's Ultrasound-on-Chip™ platform achieves what it deems a breakthrough in non-invasive neuroimaging, with implications for how humans may one day communicate and connect. Butterfly Network, Inc. ("Butterfly") (NYSE:BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today responded to Aleph Neuro (Aleph)'s public launch and announcement of what it describes as a breakthrough in non-invasive brain imaging using ultrasound. Aleph is a participant in the Butterfly Embedded™ licensing and co-development program powering a new wave of ultrasound-enabled technologies. This press rel
- INSIDERDirector Schwartz Erica was granted 25,447 shares, increasing direct ownership by 7% to 401,699 units (SEC Form 4)4 - Butterfly Network, Inc. (0001804176) (Issuer)
- INSIDERDirector Rothberg Jonathan M was granted 25,447 shares, increasing direct ownership by 0.88% to 2,905,699 units (SEC Form 4)4 - Butterfly Network, Inc. (0001804176) (Issuer)
- INSIDERDirector Robbins Larry was granted 25,447 shares, increasing direct ownership by 7% to 390,952 units (SEC Form 4)4 - Butterfly Network, Inc. (0001804176) (Issuer)
- INSIDERDirector Phanstiel S. Louise was granted 25,447 shares, increasing direct ownership by 7% to 390,952 units (SEC Form 4)4 - Butterfly Network, Inc. (0001804176) (Issuer)
- INSIDERDirector Neubauer Caroll H was granted 25,447 shares, increasing direct ownership by 35% to 98,617 units (SEC Form 4)4 - Butterfly Network, Inc. (0001804176) (Issuer)
- INSIDERDirector Edelman Elazer R was granted 25,447 shares, increasing direct ownership by 7% to 392,893 units (SEC Form 4)4 - Butterfly Network, Inc. (0001804176) (Issuer)
- SECButterfly Network Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders8-K - Butterfly Network, Inc. (0001804176) (Filer)
- PRButterfly Network Provides Commentary on Midjourney Medical's Full Body Ultrasound Scanner AnnouncementMidjourney reveals the technology behind its previously disclosed agreement with Butterfly, reimagining wide-scale access to whole body imaging and personalized health insights. Butterfly Network, Inc. ("Butterfly") (NYSE:BFLY), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today provided commentary following Midjourney's public announcement of Midjourney Medical and The Midjourney Scanner: a full-body tomographic imaging machine. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260618923795/en/ The current scanner prototype incorporates 40 Butterfly Ultrasound-on-Chip™ imagi
- PR16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart GapIssued on behalf of Ventripoint Diagnostics Ltd.As the number of people living with congenital heart disease climbs and most patients in poorer regions go without timely care, a Toronto-based AI imaging company is joining a new global alliance built to close that gap.TORONTO, ON, June 16, 2026 /CNW/ -- Equity Insider News Commentary — Congenital heart disease is the most common birth defect in the world, and the population living with it is growing, not shrinking. According to the World Heart Federation's World Heart Report 2026, congenital heart disease now affects roughly 2% of live births globally, and the number of people living with the condition has climbed to an estimated 16 million w
- PRButterfly Network to Participate in TD Cowen's Medical Devices Emerging Growth Call Series on June 18, 2026Webcast occurring at 12:00pm ET on Thursday, June 18, 2026. Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), today announced that it will participate in the TD Cowen Medical Devices Emerging Growth Call Series at 12:00pm ET on June 18, 2026. Joseph DeVivo, President, Chief Executive Officer & Chairman; John Doherty, EVP, Chief Financial Officer and David Horsley, SVP, Innovation, will take part in the discussion. To register or access the audio-only webcast, visit the Events & Presentations section of the Butterfly investor website (https://ir.butterflynetwork.com/events-and-presentations). About Butterfly Network Butterfly Network, Inc. (NYSE:BFLY) is driving a digital revolution
BFLY FAQ
7 questionsWhat does Butterfly Network Inc. do?
Butterfly Network, Inc., a digital health company, develops, manufactures, and commercializes ultrasound imaging solutions in the United States and internationally. It offers Butterfly iQ, a handheld and single-probe whole body ultrasound system; and Butterfly iQ+, a point-of-care ultrasound imaging device that connects with a smart phone or tablet. The company serves healthcare practitioners. Butterfly Network, Inc. was incorporated in 2011 and is headquartered in Guilford, Connecticut.Where does BFLY stock trade?
Butterfly Network Inc. (BFLY) is listed on NYSE.What sector and industry is BFLY in?
Butterfly Network Inc. operates in the Health Care sector, Medical Electronics industry.When did Butterfly Network Inc. go public?
Butterfly Network Inc. (BFLY) completed its IPO in 2020.What are analysts saying about BFLY?
Butterfly Network Inc. has had 8 recent analyst actions on file. The most recent action was from Oppenheimer: Perform on 2025-08-01. Recent price targets range from $225.00 to $950.00.What companies are similar to BFLY?
Notable peers in the same industry include GEHC (GE HealthCare Technologies Inc.), PHG (Koninklijke Philips N.V. NY Registry Shares), HOLX (Hologic Inc.), NNOX (NANO-X IMAGING LTD), CHEK (Check-Cap Ltd.). Compare BFLY side-by-side with any of them on Quantisnow.How can I track BFLY on Quantisnow?
Quantisnow aggregates Butterfly Network Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow BFLY to receive live email and push alerts on every new disclosure.